• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

BCG 过表达 L,D-转肽酶对结核分枝杆菌感染的保护作用。

Protective efficacy of BCG overexpressing an L,D-transpeptidase against M. tuberculosis infection.

机构信息

Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, United States of America.

出版信息

PLoS One. 2010 Oct 29;5(10):e13773. doi: 10.1371/journal.pone.0013773.

DOI:10.1371/journal.pone.0013773
PMID:21048936
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2966435/
Abstract

BACKGROUND

M. bovis Bacille Calmette-Guérin (BCG), currently the only available vaccine against tuberculosis (TB), fails to adequately protect individuals from active and latent TB infection. New vaccines are desperately needed to decrease the worldwide burden of TB.

METHODS AND FINDINGS

We created a recombinant strain of BCG that overproduces an L,D-transpeptidase in order to alter the bacterial peptidoglycan layer and consequently increase the ability of this immunogen to protect against virulent M. tuberculosis (Mtb). We demonstrate that this novel recombinant BCG protects mice against virulent Mtb at least as well as control BCG, as measured by its ability to reduce bacterial burden in lungs and spleen, reduce lung histopathology, and prolong survival. A nutrient starved recombinant BCG preparation, while offering comparable protection, elicited a response characterized by elevated levels of select Th1 cytokines.

CONCLUSIONS

Recombinant BCG overexpressing a L,D-transpeptidase that is nutrient starved elicits a stronger Th1 type response and is at least as protective as parent BCG. Results from this study suggest that nutrient starvation treatment of live BCG vaccines should be further investigated as a way to increase host induction of Th-1 related cytokines in the development of experimental anti-TB vaccines.

摘要

背景

牛型分枝杆菌卡介苗(BCG)是目前唯一可用于预防结核病(TB)的疫苗,但不能充分保护个体免受活动性和潜伏性 TB 感染。迫切需要新的疫苗来降低全球结核病负担。

方法和结果

我们创建了一种重组 BCG 菌株,该菌株过度表达 L,D-转肽酶,以改变细菌肽聚糖层,从而提高这种免疫原预防毒力结核分枝杆菌(Mtb)的能力。我们证明,这种新型重组 BCG 能够像对照 BCG 一样保护小鼠免受毒力 Mtb 的侵害,其保护作用可以通过减少肺部和脾脏的细菌负荷、减少肺部组织病理学变化和延长存活时间来衡量。饥饿营养的重组 BCG 制剂虽然提供了相当的保护作用,但引发了一种以选择性 Th1 细胞因子水平升高为特征的反应。

结论

过度表达 L,D-转肽酶的饥饿营养重组 BCG 引发了更强的 Th1 型反应,其保护作用与亲本 BCG 至少一样。这项研究的结果表明,应该进一步研究活 BCG 疫苗的饥饿营养处理方法,作为增加宿主在实验性抗 TB 疫苗中诱导 Th1 相关细胞因子的一种方式。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ba06/2966435/46ac9e0d91ba/pone.0013773.g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ba06/2966435/662ecf87f26b/pone.0013773.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ba06/2966435/435e083e5d80/pone.0013773.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ba06/2966435/c4faa548f22c/pone.0013773.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ba06/2966435/1cdbd9b333cb/pone.0013773.g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ba06/2966435/46ac9e0d91ba/pone.0013773.g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ba06/2966435/662ecf87f26b/pone.0013773.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ba06/2966435/435e083e5d80/pone.0013773.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ba06/2966435/c4faa548f22c/pone.0013773.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ba06/2966435/1cdbd9b333cb/pone.0013773.g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ba06/2966435/46ac9e0d91ba/pone.0013773.g005.jpg

相似文献

1
Protective efficacy of BCG overexpressing an L,D-transpeptidase against M. tuberculosis infection.BCG 过表达 L,D-转肽酶对结核分枝杆菌感染的保护作用。
PLoS One. 2010 Oct 29;5(10):e13773. doi: 10.1371/journal.pone.0013773.
2
Heterologous Boost Following Reduces the Late Persistent, Rather Than the Early Stage of Intranasal Tuberculosis Challenge Infection.异源加强接种可减少迟发性而非早期鼻内结核感染挑战。
Front Immunol. 2018 Oct 30;9:2439. doi: 10.3389/fimmu.2018.02439. eCollection 2018.
3
A live attenuated BCG vaccine overexpressing multistage antigens Ag85B and HspX provides superior protection against Mycobacterium tuberculosis infection.一种表达多阶段抗原 Ag85B 和 HspX 的减毒活卡介苗疫苗可提供针对结核分枝杆菌感染的卓越保护。
Appl Microbiol Biotechnol. 2015 Dec;99(24):10587-95. doi: 10.1007/s00253-015-6962-x. Epub 2015 Sep 12.
4
[Novel vaccines against M. tuberculosis].[新型抗结核分枝杆菌疫苗]
Kekkaku. 2006 Dec;81(12):745-51.
5
Evaluation of Immunogenicity and Protective Efficacy Elicited by Mycobacterium bovis BCG Overexpressing Ag85A Protein against Mycobacterium tuberculosis Aerosol Infection.过表达Ag85A蛋白的牛分枝杆菌卡介苗对结核分枝杆菌气溶胶感染引发的免疫原性和保护效力评估
Front Cell Infect Microbiol. 2016 Jan 28;6:3. doi: 10.3389/fcimb.2016.00003. eCollection 2016.
6
Next-Generation Vaccines Based on Bacille Calmette-Guérin.基于卡介苗的新一代疫苗。
Front Immunol. 2018 Feb 5;9:121. doi: 10.3389/fimmu.2018.00121. eCollection 2018.
7
Recombinant bacille Calmette-Guerin coexpressing Ag85b, CFP10, and interleukin-12 elicits effective protection against Mycobacterium tuberculosis.重组卡介苗共表达 Ag85b、CFP10 和白细胞介素-12 可有效预防结核分枝杆菌感染。
J Microbiol Immunol Infect. 2017 Feb;50(1):90-96. doi: 10.1016/j.jmii.2014.11.019. Epub 2014 Dec 11.
8
A multiple T cell epitope comprising DNA vaccine boosts the protective efficacy of Bacillus Calmette-Guérin (BCG) against Mycobacterium tuberculosis.一种包含多个 T 细胞表位的 DNA 疫苗增强了卡介苗(BCG)对结核分枝杆菌的保护效力。
BMC Infect Dis. 2020 Sep 17;20(1):677. doi: 10.1186/s12879-020-05372-1.
9
Recombinant bacillus calmette-guerin (BCG) vaccines expressing the Mycobacterium tuberculosis 30-kDa major secretory protein induce greater protective immunity against tuberculosis than conventional BCG vaccines in a highly susceptible animal model.在高度易感动物模型中,表达结核分枝杆菌30 kDa主要分泌蛋白的重组卡介苗(BCG)疫苗比传统卡介苗疫苗诱导出更强的抗结核保护性免疫。
Proc Natl Acad Sci U S A. 2000 Dec 5;97(25):13853-8. doi: 10.1073/pnas.250480397.
10
Evaluation of protective efficacy conferred by a recombinant Mycobacterium bovis BCG expressing a fusion protein of Ag85A-ESAT-6.评估表达 Ag85A-ESAT-6 融合蛋白的重组牛分枝杆菌卡介苗的保护效力。
J Microbiol Immunol Infect. 2014 Feb;47(1):48-56. doi: 10.1016/j.jmii.2012.11.005. Epub 2013 Jan 26.

引用本文的文献

1
Targeting the cell wall of Mycobacterium tuberculosis: structure and mechanism of L,D-transpeptidase 2.靶向结核分枝杆菌细胞壁:L,D-转肽酶 2 的结构与机制。
Structure. 2012 Dec 5;20(12):2103-15. doi: 10.1016/j.str.2012.09.016. Epub 2012 Oct 25.
2
Protective and therapeutic efficacy of Mycobacterium smegmatis expressing HBHA-hIL12 fusion protein against Mycobacterium tuberculosis in mice.表达 HBHA-hIL12 融合蛋白的耻垢分枝杆菌对小鼠结核分枝杆菌的保护和治疗效果。
PLoS One. 2012;7(2):e31908. doi: 10.1371/journal.pone.0031908. Epub 2012 Feb 21.
3
OX40 ligand fusion protein delivered simultaneously with the BCG vaccine provides superior protection against murine Mycobacterium tuberculosis infection.

本文引用的文献

1
The Mycobacterium tuberculosis protein LdtMt2 is a nonclassical transpeptidase required for virulence and resistance to amoxicillin.结核分枝杆菌蛋白 LdtMt2 是一种非经典转肽酶,对毒力和耐阿莫西林至关重要。
Nat Med. 2010 Apr;16(4):466-9. doi: 10.1038/nm.2120. Epub 2010 Mar 21.
2
Ag85B-ESAT-6 adjuvanted with IC31 promotes strong and long-lived Mycobacterium tuberculosis specific T cell responses in naïve human volunteers.Ag85B-ESAT-6 佐剂与 IC31 联合促进了初免人类志愿者中强烈和持久的结核分枝杆菌特异性 T 细胞应答。
Vaccine. 2010 Apr 30;28(20):3571-81. doi: 10.1016/j.vaccine.2010.02.094. Epub 2010 Mar 11.
3
Attenuated Bordetella pertussis vaccine strain BPZE1 modulates allergen-induced immunity and prevents allergic pulmonary pathology in a murine model.
OX40 配体融合蛋白与卡介苗疫苗同时给药可提供针对小鼠结核分枝杆菌感染的优异保护。
J Infect Dis. 2012 Mar 15;205(6):975-83. doi: 10.1093/infdis/jir868. Epub 2012 Feb 7.
减毒百日咳博德特氏菌疫苗株 BPZE1 调节变应原诱导的免疫反应,预防小鼠变应性肺病理。
Clin Exp Allergy. 2010 Jun;40(6):933-41. doi: 10.1111/j.1365-2222.2010.03459.x. Epub 2010 Feb 22.
4
Recognition of peptidoglycan from the microbiota by Nod1 enhances systemic innate immunity.Nod1 通过识别微生物群中的肽聚糖增强全身先天免疫。
Nat Med. 2010 Feb;16(2):228-31. doi: 10.1038/nm.2087. Epub 2010 Jan 17.
5
Bacterial thymidine kinase as a non-invasive imaging reporter for Mycobacterium tuberculosis in live animals.细菌胸苷激酶作为活体内结核分枝杆菌的非侵入性成像报告分子。
PLoS One. 2009 Jul 16;4(7):e6297. doi: 10.1371/journal.pone.0006297.
6
Immunogenicity of novel DosR regulon-encoded candidate antigens of Mycobacterium tuberculosis in three high-burden populations in Africa.结核分枝杆菌新型DosR调控子编码候选抗原在非洲三个高负担人群中的免疫原性
Clin Vaccine Immunol. 2009 Aug;16(8):1203-12. doi: 10.1128/CVI.00111-09. Epub 2009 Jun 24.
7
Tuberculosis vaccine research: the impact of immunology.结核病疫苗研究:免疫学的影响。
Curr Opin Immunol. 2009 Jun;21(3):331-8. doi: 10.1016/j.coi.2009.05.017. Epub 2009 Jun 7.
8
Novel recombinant BCG expressing perfringolysin O and the over-expression of key immunodominant antigens; pre-clinical characterization, safety and protection against challenge with Mycobacterium tuberculosis.表达产气荚膜梭菌溶血素O的新型重组卡介苗及关键免疫显性抗原的过表达;临床前特征、安全性及抗结核分枝杆菌攻击的保护作用
Vaccine. 2009 Jul 16;27(33):4412-23. doi: 10.1016/j.vaccine.2009.05.048. Epub 2009 Jun 2.
9
Epidemiology of antituberculosis drug resistance 2002-07: an updated analysis of the Global Project on Anti-Tuberculosis Drug Resistance Surveillance.2002 - 2007年抗结核药物耐药性流行病学:全球抗结核药物耐药性监测项目的最新分析
Lancet. 2009 May 30;373(9678):1861-73. doi: 10.1016/S0140-6736(09)60331-7. Epub 2009 Apr 15.
10
More vaccine efficacy studies on the recombinant Bacille Calmette-Guerin co-expressing Ag85B, Mpt64 and Mtb8.4.关于共表达Ag85B、Mpt64和Mtb8.4的重组卡介苗的更多疫苗效力研究。
Scand J Immunol. 2009 Apr;69(4):342-50. doi: 10.1111/j.1365-3083.2009.02231.x.